News
FDA Approves Ampyra to Enhance Walking Ability in Multiple Sclerosis Patients
2/2/2010
Drug Watch
The U.S. Food and Drug Administration approved Ampyra, a new medication intended to improve walking ability in individuals with multiple sclerosis, on January 22, 2010. In clinical trials, patients who took Ampyra illustrated a marked improvement in walking speed in comparison with individuals who were given placebo. Click here to read more about Ampyra.